Amylyx Pharmaceuticals, Inc. (AMLX) › Shares OutstandingAmylyx Pharmaceuticals, Inc. (AMLX) — Shares OutstandingAnnual figures by period end, from SEC filings.2021-12-31: 7.02M2022-12-31: 66.51M2023-12-31: 67.71M2024-12-31: 68.63M2025-12-31: 109.88M109.88M2021-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-31109.88M+60.1%2026-03-03Balance as of period end2024-12-3168.63M+1.4%2026-03-03Balance as of period end2023-12-3167.71M+1.8%2025-03-04Balance as of period end2022-12-3166.51M+847.4%2024-02-22Balance as of period end2021-12-317.02M—2023-03-13Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)